Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Tiotropium Test Products vs Spiriva Respimat
NCT02676297Phase 1Completed
- Sponsor
- Solventum
- Start
- Jan 2016
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of tiotropium in chronic obstructive pulmonary disease (COPD) and asthma (3 arms), sponsored by Solventum. Primary endpoint: Peak Plasma Concentration at 8 hours. Started Jan 2016; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)asthma
Beyond the preview
Go deeper on NCT02676297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02676297.